Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2006 | 1 |
2014 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.
Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11.
Lancet Oncol. 2015.
PMID: 25498218
Free article.
Clinical Trial.
Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).
Fechner G, Siener R, Reimann M, Kobalz L, Albers P; German Association Of Urologic Oncology (Auo) Bladder Cancer Study Group.
Fechner G, et al.
Int J Clin Pract. 2006 Jan;60(1):27-31. doi: 10.1111/j.1742-1241.2005.00663.x.
Int J Clin Pract. 2006.
PMID: 16409425
Clinical Trial.
Item in Clipboard
Gemcitabine monotherapy as second-line treatment in cisplatin-refractory transitional cell carcinoma - prognostic factors for response and improvement of quality of life.
Albers P, Siener R, Härtlein M, Fallahi M, Haeutle D, Perabo FG, Steiner G, Blatter J, Müller SC; German TCC Study Group of the German Association of Urologic Oncology.
Albers P, et al.
Onkologie. 2002 Feb;25(1):47-52. doi: 10.1159/000055202.
Onkologie. 2002.
PMID: 11893883
Clinical Trial.
Item in Clipboard
Cite
Cite